Agency Information Collection Request; 60-Day Public Comment Request, 59809-59810 [2020-20979]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 185 / Wednesday, September 23, 2020 / Notices
highly context dependent and while
definitions of rurality may take into
account a range of characteristics (e.g.,
population density, commuting
distance, land use, etc.), rural
definitions do not reflect any single,
inherent geographic attribute.5 FORHP’s
proposal to modify our eligibility
criteria to apply for or receive services
funded by FORHP’s rural health grants
reflects our efforts to be responsive to
stakeholder feedback and best target our
programs towards the intended
communities. This does not eliminate
the fact that other rural definitions may
be set by statute or regulation or the fact
that other programs established outside
of FORHP’s 330A authorization may
need to use a different definition of
rural to meet program goals. No single
definition of rural is perfect or advisable
given the geographic variation that
exists nationally and the varying needs
of rural programs.
khammond on DSKJM1Z7X2PROD with NOTICES
Request for Public Comment
FORHP is proposing to modify the
rural definition it uses to determine
geographic areas eligible to apply for or
receive services funded by FORHP’s
rural health grants and requests
comments from the public on the
proposed methodology described above.
This request for comments is issued
solely for information and planning
purposes; it does not constitute a
Request for Proposal, applications,
proposal abstracts, or quotations. This
request does not commit the
Government to contract for any supplies
or services or make a grant or
cooperative agreement award or take
any other official action. Further, HRSA
is not seeking proposals through this
Request for Information and will not
accept unsolicited proposals.
HRSA is not obligated to summarize
or publish a response to feedback
received, or to respond to questions
about the policy issues raised in this
request. Responders are advised that the
United States Government will not pay
for any information or administrative
costs incurred in response to this
request; all costs associated with
https://www.ers.usda.gov/topics/rural-economypopulation/rural-classifications/what-is-rural.aspx.
Accessed December 20, 2019.
5 For a deeper discussion of this topic, please see:
(a) National Academies of Sciences, Engineering,
and Medicine 2016. Rationalizing Rural Area
Classifications for the Economic Research Service:
A Workshop Summary. Washington, DC: The
National Academies Press. Accessed December 20,
2019. Available from: https://doi.org/10.17226/
21843; and (b) Ratcliffe M, Burd C, Holder K, and
Fields A, ‘‘Defining Rural at the U.S. Census
Bureau,’’ ACSGEO–1, U.S. Census Bureau,
Washington, DC, 2016. Available from: https://
www.census.gov/content/dam/Census/library/
publications/2016/acs/acsgeo-1.pdf.
VerDate Sep<11>2014
18:02 Sep 22, 2020
Jkt 250001
responding to this request will be solely
at the interested party’s expense.
List of References
Urban Area Criteria for Census 2000. Federal
Register, Vol. 67, No. 51. March 15, 2002
https://www.federalregister.gov/
documents/2002/03/15/02-6186/urbanarea-criteria-for-census-2000.
Rural Employment Trends in Recession and
Recovery. Economic Research Report
Number 172, August 2014. https://
www.ers.usda.gov/webdocs/
publications/45258/48731_
err172.pdf?v=0.
Rural America at a Glance, 2019 Edition.
https://www.ers.usda.gov/webdocs/
publications/95341/eib-212.pdf?v=3322.
The future of work in America: People and
places, today and tomorrow. McKinsey
Global Institute. July 2019. https://
www.mckinsey.com/featured-insights/
future-of-work/the-future-of-work-inamerica-people-and-places-today-andtomorrow#.
Standards for Defining Metropolitan and
Micropolitan Statistical Areas. Federal
Register/Vol. 65, No. 249/December 27,
2000. 82228–82238 https://www.bls.gov/
lau/frn249.pdf.
2010 Standards for Delineating Metropolitan
and Micropolitan Statistical Areas;
Notice. Federal Register/Vol. 75, No.
123, June 28, 2010. 37246–37252.
https://www.govinfo.gov/content/pkg/
FR-2010-06-28/pdf/2010-15605.pdf.
Thomas J. Engels,
Administrator.
[FR Doc. 2020–20971 Filed 9–22–20; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: OS–0990–xxxx]
Agency Information Collection
Request; 60-Day Public Comment
Request
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before November 23,
2020.
ADDRESSES: Submit your comments to
Sherrette.Funn@hhs.gov or by calling
(202) 795–7714.
FOR FURTHER INFORMATION CONTACT:
When submitting comments or
requesting information, please include
the document identifier 0990-New-60D,
and project title for reference, to
SUMMARY:
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
59809
Sherrette Funn, the Reports Clearance
Officer, Sherrette.Funn@hhs.gov, or call
202–795–7714.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: HHS
Teletracking COVID–19 Portal (U.S.
Healthcare COVID–19 Portal).
Type of Collection: In use without an
OMB number.
OMB No.: 0990–XXXX OS/OCIO.
Abstract: The data collected through
this ICR informs the Federal
Government’s understanding of disease
patterns and furthers the development
of policies for prevention and control of
disease spread and impact related to the
2019 Novel Coronavirus (COVID–19).
One of the most important uses of the
data collected through this ICR is to
determine critical allocations of limited
supplies (e.g., protective equipment and
medication). For instance, this
collection has been used to distribute
Remdesivir, a vital therapeutic that HHS
distributes to the American healthcare
system, via distinct data calls on regular
intervals. As of July 10, HHS reduced
the number requests for data from
hospitals to support allocations of
Remdesivir. HHS has stopped sending
out one-time requests for data to aid in
the distribution of Remdesivir or any
other treatments or supplies. This
consolidated daily reporting is the only
mechanism used for the distribution
calculations, and daily reports are
needed to ensure accurate calculations.
Type of Respondent: We acknowledge
the burden placed on many hospitals,
including resource constraints, and have
allowed for some flexibilities, such as
back-submissions or submitting every
business days, with the understanding
that respondents may not have
sufficient staff working over the
weekend. It is our belief that collection
of this information daily is the most
effective way to detect outbreaks and
needs for Federal assistance over time,
by hospital and geographical area, and
to alert the appropriate officials for
action. It’s requested that 5,500
hospitals, submit data daily on the
E:\FR\FM\23SEN1.SGM
23SEN1
59810
Federal Register / Vol. 85, No. 185 / Wednesday, September 23, 2020 / Notices
number of patients tested for COVID–19,
as well as information on bed capacity
and requirements for other supplies.
The HHS Teletracking COVID–19
Portal (U.S. Healthcare COVID–19
Portal) includes some data that were
initially submitted by hospitals to HHS
through CDC’s National Healthcare
Safety Network (NHSN) COVID–19
Module (OMB Control No. 0920–1290,
approved 03/26/2020). Over the last
several months time, the guidance for
which data elements should be sent to
HHS and through which method was
updated at the request of the White
House Coronavirus Task Force and
other leaders to better inform the
response.
ANNUALIZED BURDEN HOUR TABLE
Number
responses
per
respondent
Average
burden per
response
(in hours)
Total burden
hours
Form name
Hospitals ...........................................
HHS Teletracking COVID–19 Portal
(U.S. Healthcare COVID–19 Portal).
5,500
365
1.5
3,011,250
Total ...........................................
...........................................................
........................
........................
........................
3,011,250
Dated: September 15, 2020.
Sherrette A. Funn,
Office of the Secretary, Paperwork Reduction
Act Reports Clearance Officer.
[FR Doc. 2020–20979 Filed 9–22–20; 8:45 am]
BILLING CODE 4150–04–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
respondents
Type of respondent
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group Adult Psychopathology and Disorders
of Aging Study Section.
Date: October 15–16, 2020.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Benjamin Greenberg
Shapero, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3182, MSC 7848, Bethesda, MD 20892,
(301) 402–4786, shaperobg@mail.nih.gov.
VerDate Sep<11>2014
18:02 Sep 22, 2020
Jkt 250001
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group
Musculoskeletal Tissue Engineering Study
Section.
Date: October 20–21, 2020.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Srikanth Ranganathan,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4214,
MSC 7802, Bethesda, MD 20892, (301) 435–
1787, srikanth.ranganathan@nih.gov.
Name of Committee: Interdisciplinary
Molecular Sciences and Training Integrated
Review Group Cellular and Molecular
Technologies Study Section.
Date: October 20–21, 2020.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Tatiana V Cohen, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Room 5213,
Bethesda, MD 20892, (301) 455–2364,
tatiana.cohen@nih.gov.
Name of Committee: Biological Chemistry
and Macromolecular Biophysics Integrated
Review Group Synthetic and Biological
Chemistry B Study Section.
Date: October 20–21, 2020.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michael Eissenstat, Ph.D.,
Scientific Review Officer, BCMB IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4166,
MSC 7806, Bethesda, MD 20892, (301) 435–
1722, eissenstatma@csr.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group Cellular,
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
Molecular and Integrative Reproduction
Study Section.
Date: October 20–21, 2020.
Time: 9:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Elaine Sierra-Rivera, MS,
BS, Ph.D., Scientific Review Officer, EMNR
IRG, Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 6182 MSC 7892, Bethesda, MD 20892,
(301) 435–2514, riverase@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel PAR Panel:
International Research Ethics Education and
Curriculum Development.
Date: October 20, 2020.
Time: 9:30 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Seetha Bhagavan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194,
MSC 7846, Bethesda, MD 20892, (301) 237–
9838, bhagavas@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Exploration
of Antimicrobial Therapeutics and
Resistance.
Date: October 20–21, 2020.
Time: 9:30 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Susan Daum, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3202,
Bethesda, MD 20892, (301) 827–7233,
susan.boyle-vavra@nih.gov.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group Instrumentation and Systems
Development Study Section.
Date: October 20–21, 2020.
E:\FR\FM\23SEN1.SGM
23SEN1
]]>Agencies
[Federal Register Volume 85, Number 185 (Wednesday, September 23, 2020)]
[Notices]
[Pages 59809-59810]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-20979]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Document Identifier: OS-0990-xxxx]
Agency Information Collection Request; 60-Day Public Comment
Request
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995, the Office of the Secretary (OS), Department of Health and
Human Services, is publishing the following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be received on or before November 23,
2020.
ADDRESSES: Submit your comments to [email protected] or by calling
(202) 795-7714.
FOR FURTHER INFORMATION CONTACT: When submitting comments or requesting
information, please include the document identifier 0990-New-60D, and
project title for reference, to Sherrette Funn, the Reports Clearance
Officer, [email protected], or call 202-795-7714.
SUPPLEMENTARY INFORMATION: Interested persons are invited to send
comments regarding this burden estimate or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
Title of the Collection: HHS Teletracking COVID-19 Portal (U.S.
Healthcare COVID-19 Portal).
Type of Collection: In use without an OMB number.
OMB No.: 0990-XXXX OS/OCIO.
Abstract: The data collected through this ICR informs the Federal
Government's understanding of disease patterns and furthers the
development of policies for prevention and control of disease spread
and impact related to the 2019 Novel Coronavirus (COVID-19). One of the
most important uses of the data collected through this ICR is to
determine critical allocations of limited supplies (e.g., protective
equipment and medication). For instance, this collection has been used
to distribute Remdesivir, a vital therapeutic that HHS distributes to
the American healthcare system, via distinct data calls on regular
intervals. As of July 10, HHS reduced the number requests for data from
hospitals to support allocations of Remdesivir. HHS has stopped sending
out one-time requests for data to aid in the distribution of Remdesivir
or any other treatments or supplies. This consolidated daily reporting
is the only mechanism used for the distribution calculations, and daily
reports are needed to ensure accurate calculations.
Type of Respondent: We acknowledge the burden placed on many
hospitals, including resource constraints, and have allowed for some
flexibilities, such as back-submissions or submitting every business
days, with the understanding that respondents may not have sufficient
staff working over the weekend. It is our belief that collection of
this information daily is the most effective way to detect outbreaks
and needs for Federal assistance over time, by hospital and
geographical area, and to alert the appropriate officials for action.
It's requested that 5,500 hospitals, submit data daily on the
[[Page 59810]]
number of patients tested for COVID-19, as well as information on bed
capacity and requirements for other supplies.
The HHS Teletracking COVID-19 Portal (U.S. Healthcare COVID-19
Portal) includes some data that were initially submitted by hospitals
to HHS through CDC's National Healthcare Safety Network (NHSN) COVID-19
Module (OMB Control No. 0920-1290, approved 03/26/2020). Over the last
several months time, the guidance for which data elements should be
sent to HHS and through which method was updated at the request of the
White House Coronavirus Task Force and other leaders to better inform
the response.
Annualized Burden Hour Table
----------------------------------------------------------------------------------------------------------------
Number Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hours) hours
----------------------------------------------------------------------------------------------------------------
Hospitals..................... HHS Teletracking 5,500 365 1.5 3,011,250
COVID-19 Portal
(U.S.
Healthcare
COVID-19
Portal).
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 3,011,250
----------------------------------------------------------------------------------------------------------------
Dated: September 15, 2020.
Sherrette A. Funn,
Office of the Secretary, Paperwork Reduction Act Reports Clearance
Officer.
[FR Doc. 2020-20979 Filed 9-22-20; 8:45 am]
BILLING CODE 4150-04-P
